T cell activation markers and methods for evaluating T cell activation
JP2026521344APending Publication Date: 2026-06-30JUNO THERAPEUTICS INC
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- JUNO THERAPEUTICS INC
- Filing Date
- 2024-05-22
- Publication Date
- 2026-06-30
Smart Images

Figure 2026521344000001_ABST
Abstract
This disclosure relates to a method for evaluating the activation state of T cells in a cell composition that may be used in connection with cell therapy, or to a method for generating cells for cell therapy. The cells in the cell composition may express recombinant receptors, such as chimeric receptors, such as chimeric antigen receptors (CARs), or other transgenic receptors such as T cell receptors (TCRs). The method provides markers and methods for using them to evaluate the activation of T cells in a cell composition.
Need to check novelty before this filing date? Find Prior Art